Incubate Comment in Response to Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical IngredientsIncubate CoalitionMay 6, 20250 min readRequest for Comments Section 232 - Incubate.pdfDownload PDF • 214KB
Senator Todd Young on China, innovation, and the future of U.S. competitiveness on the Making Medicine podcast
Incubate and Manatt Release New Report: Regulatory Instability at FDA Is Reshaping Biotech InvestmentWASHINGTON (April 21) -- Today, Incubate, in partnership with Manatt Health, released new insights from interviews with leading biopharmaceutical investors showing that instability at the Food and Dr
Comments